Advanced Brain Monitoring News

2007
2006
2005
2004

News 2007

COMMENTARY ADVOCATES WIDESPREAD SCREENING OF TRUCK DRIVERS FOR OBSTRUCTIVE SLEEP APNEA
[Wednesday, September 5, 2007]

A recent peer-reviewed study conducted by Advanced Brain Monitoring, Inc. found that as many as 50 percent of transportation workers have undiagnosed obstructive sleep apnea (OSA), a potentially life-threatening breathing-related sleep disorder that often goes undiagnosed and untreated. An accompanying legal article emphasizes the responsibility drivers now have to ensure they are fit for duty to be socially responsible, avoid tort liability, and possibly even jail time, if they cause an accident. It also identifies steps that employers and clinicians can take to reduce the likelihood of paying punitive damages if a driver has an accident due to OSA. View full Press Release.

RELEASE OF 2007 NEWSLETTER

Advanced Brain Monitoring is pleased to present their 2007 Newsletter.

ADVANCED BRAIN MONITORING ARES™ RECEIVES FROST & SULLIVAN PRODUCT INNOVATION AWARD
[Tuesday, May 22, 2007]

Frost & Sullivan presented Advanced Brain Monitoring, Inc. with the 2006 Product Innovation Award for the Apnea Risk Evaluation System (ARESTM) in the field of European sleep diagnostics and associated data management systems market. The Frost & Sullivan Award for Product Innovation is presented each year to companies that showcase new product introductions. The honor also recognizes competitive advantage citing unique or revolutionary technology, acceptance in the marketplace or the value addition of services to customers. View full Press Release.

News 2006

RELEASE OF 2006 NEWSLETTER

Advanced Brain Monitoring is pleased to present their 2006 Newsletter.

ADVANCED BRAIN MONITORING TO PRESENT AT DENTAL SLEEP MEDICINE CONFERENCE
[Thursday, June 15, 2006]

Dr. Philip Westbrook, Medical Director of Advanced Brain Monitoring, in collaboration with Dr. Todd Morgan of Scripps Memorial Hospital will present data validating the efficacy of oral appliance therapy for OSA at the American Academy of Dental Sleep Medicine annual meeting in Salt Lake City, UT, June 15-17. The presentation, entitled “In-Home Evaluation of Efficacy and Titration of a Mandibular Advancement Device for Obstructive Sleep Apnea”, reports how all subjects, even those suffering from severe OSA, obtained significant benefits from oral appliance therapy.

News 2005

ADVANCED BRAIN MONITORING RECEIVES CE MARK FOR APNEA RISK EVALUATION SYSTEM (ARES) FOR IN-HOME DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA
[Monday, February 14, 2005]

Advanced Brain Monitoring, Inc. today announced that it received the CE Mark in the European Union for its Apnea Risk Evaluation System (ARES). With this CE Mark, Advanced Brain Monitoring can now market the ARES in the European Union. The ARES was cleared by the FDA in 2004. The patented ARES is an easy-to-apply, in-home system for diagnosing obstructive sleep apnea (OSA). The ARES combines a miniaturized, battery-powered device to measure blood oxygen levels, pulse rate, snoring sounds, nasal pressure and head position/movement with a questionnaire to assess known risk factors. A multi-site clinical trial, including direct comparisons with laboratory testing and in-home studies on 280 participants, proved ARES was as accurate as the gold standard laboratory sleep study. View Press Release.

ADVANCED BRAIN MONITORING TO PARTICIPATE IN 1ST INTERNATIONAL CONFERENCE ON AUGMENTED COGNITION
[Thursday, July 21, 2005]

Advanced Brain Monitoring, Inc., is pleased to announce its participation in the 1st International Conference on Augmented Cognition held jointly with the 11th annual International Conference on Human-Computer Interaction to be held in Las Vegas, Nevada, from July 22 to 27, 2005, at the Caesars Palace Hotel and Convention Center. The company will present findings from recent research on real-time EEG systems that monitor the brain’s electrical activity to detect fatigue, assess performance, and provide interactive feedback to the operator. View Press Release.

ADVANCED BRAIN MONITORING ANNOUNCES PARTICIPATION IN INTERNATIONAL CONFERENCE ON FATIGUE MANAGEMENT IN TRANSPORTATION OPERATIONS
[Friday, August 12, 2005]

Advanced Brain Monitoring, Inc., is pleased to present its comprehensive program for addressing Obstructive Sleep Apnea (OSA) in the workplace at the 2005 International Conference on Fatigue Management in Transportation Operations to be held in Seattle, Washington, from September 11 to 15, 2005, at the Sheraton Seattle Hotel and Towers.
“OSA is a highly prevalent disorder and an important preventable cause of accidents at work and on the road,” commented Dr. Philip Westbrook, Chief Medical Officer of Advanced Brain Monitoring. “Untreated OSA can result in daytime drowsiness, memory impairment, and increased risk for hypertension, diabetes, and cardiovascular disease.” View Press Release.

STUDY PUBLISHED IN CHEST FINDS APNEA RISK EVALUATION SYSTEM AN ACCURATE AND COST-EFFECTIVE ALTERNATIVE TO POLYSOMNOGRAPHY
[Wednesday, October 26, 2005]

Advanced Brain Monitoring, Inc., today announced the Apnea Risk Evaluation System (ARES™) was proven accurate for screening and diagnosis of obstructive sleep apnea (OSA), according to the study “Description and Validation of the Apnea Risk Evaluation System: A Novel Method to Diagnose Sleep Apnea-Hypopnea in the Home” in the October 2005 issue of CHEST – The Cardiopulmonary and Critical Care Journal.
The multi-site study, funded by the NIH’s National Heart, Lung, and Blood Institute, was the largest of its kind validating an in-home system for the diagnosis of OSA, with 284 simultaneous in-lab polysomnography (PSG) and ARES studies and 187 comparisons of PSG with 2-night unattended in-home ARES studies. View Press Release.

News 2004

FDA CLEARS ADVANCED BRAIN MONITORING’S APNEA RISK EVALUATION SYSTEM (ARES™) FOR IN-HOME DIAGNOSIS OF OBSTRUCTIVE SLEEP APNEA
[Wednesday, October 20, 2004]

Advanced Brain Monitoring, Inc. today announced it received marketing clearance from the U.S. Food and Drug Administration (FDA) for its Apnea Risk Evaluation System (ARES). The patented ARES is an easy-to-apply, in-home system for diagnosing obstructive sleep apnea (OSA). The ARES combines a miniaturized, battery-powered device to measure blood oxygen levels, pulse rate, snoring sounds, nasal pressure and head position/movement with a questionnaire to assess known risk factors. A multi-site clinical trial, including direct comparisons with laboratory testing and in-home studies on 280 participants, proved ARES was as accurate as the gold standard laboratory sleep study. View press release.

ADVANCED BRAIN MONITORING AWARDED U.S. PATENT FOR APNEA RISK EVALUATION SYSTEM (ARES™)
[Monday, October 18, 2004]

Advanced Brain Monitoring has been awarded a U.S. Patent for the Apnea Risk Evaluation System (ARES), designed for in-home diagnosis of obstructive sleep apnea. The patent, entitled “Sleep Apnea Risk Evaluation”, was issued patent number 6,811,538 by the U.S. Patent and Trademark Office. The ARES combines a miniaturized, battery-powered device to measure blood oxygen levels, pulse rate, snoring sounds, nasal pressure and head position/movement with a questionnaire to assess known risk factors. The system includes the first pulse-oximeter designed specifically to characterize sleep-disordered breathing. The patent will be issued on November 2, 2004.

INTERNATIONAL JOURNAL OF HUMAN-COMPUTER INTERACTION PUBLISHES ARTICLE ON ADVANCED BRAIN MONITORING'S EEG SYSTEM
[Tuesday, July 20, 2004]

Future military and industrial applications of Advanced Brain Monitoring’s EEG system are discussed in the July 2004 issue of the International Journal of Human-Computer Interaction. The article, “Real-Time Analysis of EEG Indices of Alertness, Cognition and Memory Acquired with a Wireless EEG Headset”, presents an integrated solution for mobile acquisition and real-time analysis of the electroencephalogram (EEG) to monitor indices of alertness, cognition and memory. The theme of this special issue of the journal, “Augmented Cognition”, suggests that integration of physiological monitoring into the man-machine interface holds great promise for real-time assessment of operator status and intelligent allocation of tasks between machines and humans.

ADVANCED BRAIN MONITORING TO PRESENT AT SLEEP MEDICINE CONFERENCE
[Thursday, June 03, 2004]

Dr. Philip Westbrook, Medical Director of Advanced Brain Monitoring, will present data validating the Apnea Risk Evaluation System (ARES) and the Alertness and Memory Profiling System (AMP) at the Associated Professional Sleep Societies annual meeting in Philadelphia, PA, June 5 – 10. The ARES presentation, “A Limited-Channel Single-Site System to Diagnose Obstructive Sleep Apnea (OSA): Comparison of Full Polysomnography (PSG) with In-home and In-Lab Recordings”, includes data acquired from 270 patients and healthy controls to validate the ARES as a system for diagnosing OSA. The AMP study was designed to identify changes in alertness and memory in response to treatment of OSA with Continuous Positive Airway Pressure (CPAP). The presentation, “Quantification of Alertness, Memory and Neurophysiological Changes in Sleep Apnea Patients Following Treatment with nCPAP”, reports AMP data acquired from over 100 OSA patients and healthy controls studied repeatedly over a 3-month period.